14.05.2018 • 6 Min.

The White House laid out measures to tackle high list prices for drugs last week, hitting out at "freeloading" foreign countries that benefit from US pharmaceutical research. The FT's David Crow explains. Hosted on Acast. See acast.com/privacy for more information.